Viridian Therapeutics, Inc.\DE·4

Sep 30, 7:10 PM ET

Mahoney Stephen F. 4

4 · Viridian Therapeutics, Inc.\DE · Filed Sep 30, 2024

Insider Transaction Report

Form 4
Period: 2024-09-27
Mahoney Stephen F.
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2024-09-27$23.33/sh+21,400$499,26221,400 total

Documents

2 files